We provide information, give support, sponsor medical advice and create bonds for families and children with achondroplasia and other forms of rare bone dysplasia
Search ...
EN
ES
PT
Donations
Achondroplasia
About Us
News
Events
Galleries
Library
Contacts
People
History
How ALPE began. These are our milestones
People
Who we are
Community
Join us
ALPE Support
How we can help
Collaboration
How you can help
Medicine and science
Early intervention
Educacion and society
Education
Medicine & Science
Society & Culture
The method of our time is to use not one but multiple exploration models.
Marshall McLuhan
Scientific Research
Clinical Management
Physiotherapy
Nutrition
>> Body Mass Index (BMI): The Case for Condition-Specific Cut-Offs for Overweight and Obesity in Skeletal Dysplasias (Schulze K et al., 2013)(pdf)
>> Neutral Endopeptidase-Resistant C-Type Natriuretic Peptide Variant Represents a New Therapeutic Approach for Treatment of Fibroblast Growth Factor Receptor 3 - related dwarfism (Wendt D et al., 2015) (pdf)
>> Postnatal Soluble FGFR3 Therapy Rescues Achondroplasia Symptoms and Restores Bone Growth in Mice (Garcia S et al., 2015) (pdf)
>> Statin treatment rescues FGFR3 skeletal dysplasia phenotypes (Yamashita A et al., 2014) (pdf)
>> Airway Malacia in Children with Achondroplasia (Dessoffy K, Modaff P, Pauli R, 2013)(pdf)
Page 3 of 3
Start
Prev
1
2
3
Next
End
Sign up for regular updates
SUBSCRIBE